Investigative Site

San Diego, California 92123

0 studies enrolling now · 16 studies all time

What they study most

Chronic Idiopathic Constipation, Chronic Obstructive Pulmonary Disease, Constipation, Healthy, Heavy Menstrual Bleeding, Influenza A, Irritable Bowel Syndrome With Diarrhea (IBS-D), Menorrhagia, Obesity, Opioid-induced Constipation, Overactive Bladder (OAB), Overweight

Studies at this site

• A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A — Stopped early
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed
• Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo — Completed
• Safety and Efficacy of the SMART Device for Overweight and Obese Adults — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease — Completed
• Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed
• Safety Study of XP12B in Women With Menorrhagia — Completed
• Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed